Verapamil Therapy: A New Approach to the Pharmacologic Treatment of Hypertrophic Cardiomyopathy
نویسنده
چکیده
Treadmill exercise capacity and symptomatic status were evaluated in 19 patients with hypertrophic cardiomyopathy while on placebo, low and high dosages of propranolol and low and high dosages of verapamil. Exercise duration on placebo was 6.1 ± 0.8 minutes. Verapamil administration improved exercise capacity by 26 ± 8% (1.6 ± 0.5 minutes; p < 0.005); propranolol improved exercise capacity by 21 ± 8% (1.3 ± 0.5 minutes; p < 0.025). Twelve patients on verapamil and 11 on propranolol improved their exercise duration by at least 15% compared with placebo. No patient on verapamil but three on propranolol had more than 15% deterioration in exercise capacity. Seven patients considered their symptomatic status "best" while
منابع مشابه
Verapamil therapy: a new approach to pharmacologic treatment of hypertrophic cardiomyopathy.
The hemodynamic and clinical effects of verapamil administration were examined in patients with hypertrophic cardiomyopathy. Infusion of 0.021 mg/kg/min of verapamil decreased the basal left ventricular outflow tract gradient from 94 +/- 14 to 49 +/- 14 mm Hg, while cardiac index increased from 2.5 +/- 0.2 to 2.8 +/- 0.2 L/min/sq m. Orally administered, 80 or 120 mg four times daily (QID), incr...
متن کاملHypertrophic obstructive cardiomyopathy: mechanism of obstruction and response to therapy.
Hypertrophic cardiomyopathy is a primary, usually familial, disorder of heart muscle whose primary feature is muscular hypertrophy without recognized cause that encroaches on the ventricular chamber, reducing chamber area and volume. In roughly 25% of cases, there is associated obstruction to left ventricular outflow (hypertrophic obstructive cardiomyopathy [HOCM]). This article details the mec...
متن کاملApical Hypertrophic Cardiomyopathy in a Case with Chest Pain and Family History of Sudden Cardiac Death: A Case Report
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease, which is caused by a multitude of mutations in genes encoding proteins of the cardiac sarcomere (1). Apical hypertrophic cardiomyopathy (AHCM) is an uncommon type of HCM. The sudden cardiac death is less likely to occur in the patients inflicted with AHCM (2). Herein, we presented the case of a 29-year-old man ...
متن کاملVerapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.
Verapamil is extremely effective in the treatment of patients with hypertrophic cardiomyopathy. However, the basic physiologic actions of the drug may lead to serious adverse effects. An appreciation of this and an understanding of when these adverse effects are most likely to occur will minimize the potential of verapamil to cause serious complications in patients with hypertrophic cardiomyopa...
متن کاملA New Mutation Causing Severe Infantile-Onset Pompe Disease Responsive to Enzyme Replacement Therapy
Pompe disease (PD), also known as “glycogen storage disease type II (OMIM # 232300)” is a rare autosomal recessive disorder characterized by progressive glycogen accumulation in cellular lysosomes. It ultimately leads to cellular damage. Infantile-onset Pompe disease (IOPD) is the most severe type of this disease and is characterized by severe hypertrophic cardiomyopathy and generalized hypoton...
متن کامل